Search

everythinglearnresearchcommunity

for

Search:↓

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Hair cortisol may be a good indicator of recent mood in people with bipolar disorder.

Early diagnosis and personalized treatments are crucial for better hair loss management.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Some psychiatric medications can cause reversible hair loss.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

The COVID-19 pandemic increased symptoms in people with skin picking and hair pulling disorders.

People with trichotillomania or skin picking disorder generally sleep worse than those without these conditions.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Societal pressure for the perfect body leads to health risks and disorders.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.